Related Experiment Video
Updated: Aug 2, 2025
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.7K
[Combination strategies for checkpoint inhibition: Current practices and perspectives]
Chloé Dussart1, Baptiste Decaux-Tramoni1, Stanislas Quesada2
1CHU de Nîmes, service d'oncologie médicale, 4, rue du Professeur-Robert-Debré, 30900 Nîmes, France.
Bulletin Du Cancer
|April 13, 2023
Summary
T-cell checkpoint inhibitors like PD-1 and CTLA-4 have transformed cancer treatment. New immunotherapy combinations and emerging targets offer improved patient outcomes in solid tumors.
Area of Science:
- Immunology
- Oncology
- Cancer Therapeutics
Context:
- T-cell checkpoint blockade therapies, including PD-1 and CTLA-4 inhibitors, have significantly improved cancer treatment outcomes.
- The success in melanoma highlights the potential for synergistic immunotherapy combinations.
Purpose:
- To review approved and emerging immunotherapy combinations for solid tumors.
- To summarize novel immunomodulatory targets and clinical trials in the tumor microenvironment.
Summary:
- Focuses on established immunotherapy combinations with proven efficacy in solid tumors.
- Discusses emerging targets and immunomodulatory molecules currently under clinical investigation.
- Highlights the potential of combining different immunotherapies for enhanced anti-cancer effects.
Impact:
- Provides an overview of current and future directions in cancer immunotherapy.
- Informs clinicians and researchers about promising combination strategies.
- Aims to improve patient prognosis through advanced immunotherapy approaches.
Keywords:
Anti-CTLA-4Anti-LAG-3Anti-PD-1/L1Immune checkpoint inhibitorImmunotherapyImmunothérapieInhibiteur de points de contrôle immunitaireMore Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
02:19The Spindle Assembly Checkpoint
3.2K
The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.2K
01:28The Cell Cycle Control System
3.1K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
3.1K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K